Disclaimer to the Online Edition
This Manual has been designed for use in the NICU at London Health Sciences Centre (LHSC), London, Ontario, Canada, and represents clinical practice at this institution. The information contained within the Manual may not be applicable to other centres. If users of this Manual are not familiar with a drug, it is recommended that the official monograph be consulted before it is prescribed and administered. Any user of this information is advised that the contributors, Editor and LHSC are not responsible for any errors or omissions, and / or any consequences arising from the use of the information in this Manual.
fluticasone
Indication
- An inhaled corticosteroid used in the treatment of bronchopulmonary dysplasia
Dosage Guidelines
- 125 – 250 micrograms (1 or 2 puffs) INH q12h
Administration
- Inhaler must be primed prior to first use – remove the mouthpiece, shake canister well for 5 seconds, then actuate the inhaler. Shake and actuate a second time.
- Shake canister well for 5 seconds before each spray
- Respiratory Therapist to administer each dose with an aerochamber
- Rinse or swab mouth with water after each administration
Adverse Effects
- Throat irritation
- Upper respiratory infection
- Oral candidiasis
Comments
- Monitor mouth and perineum for candidiasis
- Onset: within 24 hours
- Maximum effect: 1 to 2 weeks
Supplied As
- 125 microgram/puff inhalation aerosol metered dose inhaler
References
LexiComp Pediatric and Neonatal